PrEP clinical trials at UC Davis

1 research study open to eligible people

Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
open to eligible people ages 16 years and up
The goal of this clinical study is to test how well the study drug, lenacapavir (LEN), works in preventing the risk of HIV.
San Francisco, California and other locations

Last updated: October 23, 2024